TriMark Publications is a Global Leader in Biotechnology, Healthcare and Life Sciences Publishing

Point of Care Testing: Innovation on the Move
From Nanotechnology to Personalized Medicine

Monday, October 22, 2007
at
The Princeton Club of New York
located at
15 West 43rd Street (b/w Fifth and Sixth Avenues)
New York, New York

Overview:

The TriMark Point of Care Diagnostics 2007 Conference has been organized to provide a critical examination of the point of care industry, as well as insight from key industry leaders concerning cutting edge point of care technology, structuring mutually beneficial deals and the point of care industry’s impact on the field of in vitro diagnostics. This conference will also provide an integral forum for leaders in point of care, in vitro diagnostics and laboratories to share ideas, network with other delegates and advance understanding of the potential of new point of care technologies. The Conference's keynote speaker is:

James H. Nichols, Ph.D., DABCC, FACB

Dr. Nichols is an Associate Professor of Pathology at Tufts University School of Medicine and Director, Clinical Chemistry for Baystate Health in Springfield, MA. Dr. Nichols received his B.A. in General Biology/Pre-medicine from Revelle College, University of California at San Diego. He went on to complete a Masters and Doctorate in Biochemistry from the University of Illinois, Urbana-Champaign. Dr. Nichols was a fellow in the Postdoctoral Training Program in Clinical Chemistry at the Mayo Clinic, Rochester, MN. He is board certified in both Clinical Chemistry and Toxicological Chemistry by the American Board of Clinical Chemistry. Dr. Nichols spent several years as Associate Director of Clinical Chemistry, Director of Point-of-Care Testing, and an Associate Professor of Pathology at Johns Hopkins Medical Institutions prior to moving to Massachusetts. Baystate Health includes Franklin Medical Center, Mary Lane Hospital and Baystate Medical Center, a leading acute care center in New England. Dr. Nichols is responsible for Clinical Chemistry including core automated chemistry, immunoassay, endocrinology, toxicology/therapeutic drug analysis, esoteric and point of care testing conducted through Baystate Reference Laboratories, one of America’s largest hospital-based outreach programs. Dr. Nichols’ research interests span evidence-based medicine, information management, laboratory automation, point-of-care testing and toxicology.